Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Monane

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Population Health Management|February 27, 2014
Economic utility of a blood-based genomic test for the assessment of patients with symptoms suggestive of obstructive coronary artery diseaseLouis I Hochheiser, Jessie L Juusola, Mark Monane, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthWilliam J Canestro, Mark Monane, Randall J Bateman, et al.
Population Health Management|March 28, 2024
Use of a Blood Biomarker Test Improves Economic Utility in the Evaluation of Older Patients Presenting with Cognitive ImpairmentWilliam J Canestaro, Randall J Bateman, David M Holtzman, et al.
Population Health Management|February 26, 2015
The diagnosis of CAD in women: addressing the unmet need - a report from the national expert roundtable meetingJanice L Clarke, Joseph L Ladapo, Mark Monane, et al.
Critical Pathways in Cardiology|May 18, 2013
The clinical utility of gene expression testing on the diagnostic evaluation of patients presenting to the cardiologist with symptoms of suspected obstructive coronary artery disease: results from the IMPACT (Investigation of a Molecular Personalized Coronary Gene Expression Test on Cardiology Practice Pattern) trialJohn A McPherson, Kelly Davis, May Yau, et al.
The American Journal of Medicine|December 21, 2016
Clinical Utility of a Precision Medicine Test Evaluating Outpatients with Suspected Obstructive Coronary Artery DiseaseJoseph A Ladapo, Matt Budoff, David Sharp, et al.
Menopause (New York, N.Y.)|April 2, 2015
Use of a blood test incorporating age, sex, and gene expression influences medical decision-making in the evaluation of women presenting with symptoms suggestive of obstructive coronary artery disease: summary results from two ambulatory care studies in primary careJoseph A Ladapo, Lee Herman, Bonnie H Weiner, et al.
Journal of the American Board of Family Medicine : JABFM|March 11, 2014
Utility of a genomic-based, personalized medicine test in patients presenting with symptoms suggesting coronary artery diseaseLee Herman, James Froelich, Dino Kanelos, et al.
Managed Care (Langhorne, Pa.)|July 11, 2018
Economic Outcomes of a Precision Medicine Blood Test To Assess Obstructive Coronary Artery Disease: Results from the PRESET RegistryJoseph A Ladapo, Matthew J Budoff, Pejman Azarmina, et al.
Journal of the American Geriatrics Society|December 7, 2017
Utility of a Precision Medicine Test in Elderly Adults with Symptoms Suggestive of Coronary Artery DiseaseJoseph A Ladapo, Matthew J Budoff, David Sharp, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Population Health Management|February 27, 2014
Economic utility of a blood-based genomic test for the assessment of patients with symptoms suggestive of obstructive coronary artery diseaseLouis I Hochheiser, Jessie L Juusola, Mark Monane, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthWilliam J Canestro, Mark Monane, Randall J Bateman, et al.
Population Health Management|March 28, 2024
Use of a Blood Biomarker Test Improves Economic Utility in the Evaluation of Older Patients Presenting with Cognitive ImpairmentWilliam J Canestaro, Randall J Bateman, David M Holtzman, et al.
Population Health Management|February 26, 2015
The diagnosis of CAD in women: addressing the unmet need - a report from the national expert roundtable meetingJanice L Clarke, Joseph L Ladapo, Mark Monane, et al.
Critical Pathways in Cardiology|May 18, 2013
The clinical utility of gene expression testing on the diagnostic evaluation of patients presenting to the cardiologist with symptoms of suspected obstructive coronary artery disease: results from the IMPACT (Investigation of a Molecular Personalized Coronary Gene Expression Test on Cardiology Practice Pattern) trialJohn A McPherson, Kelly Davis, May Yau, et al.
The American Journal of Medicine|December 21, 2016
Clinical Utility of a Precision Medicine Test Evaluating Outpatients with Suspected Obstructive Coronary Artery DiseaseJoseph A Ladapo, Matt Budoff, David Sharp, et al.
Menopause (New York, N.Y.)|April 2, 2015
Use of a blood test incorporating age, sex, and gene expression influences medical decision-making in the evaluation of women presenting with symptoms suggestive of obstructive coronary artery disease: summary results from two ambulatory care studies in primary careJoseph A Ladapo, Lee Herman, Bonnie H Weiner, et al.
Journal of the American Board of Family Medicine : JABFM|March 11, 2014
Utility of a genomic-based, personalized medicine test in patients presenting with symptoms suggesting coronary artery diseaseLee Herman, James Froelich, Dino Kanelos, et al.
Managed Care (Langhorne, Pa.)|July 11, 2018
Economic Outcomes of a Precision Medicine Blood Test To Assess Obstructive Coronary Artery Disease: Results from the PRESET RegistryJoseph A Ladapo, Matthew J Budoff, Pejman Azarmina, et al.
Journal of the American Geriatrics Society|December 7, 2017
Utility of a Precision Medicine Test in Elderly Adults with Symptoms Suggestive of Coronary Artery DiseaseJoseph A Ladapo, Matthew J Budoff, David Sharp, et al.
Pageof 3